Our Mission

NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.

Visit NASCSA forum/newsgroup

Important News & Announcements

DEA's 2nd Annual Supply Chain Conference to Take Place April 30-May 2

Posted 3/31/2024

The Drug Enforcement Administration (DEA), Diversion Control Division, is hosting a Supply Chain Conference April 30-May 2, 2024, at the Four Points by Sheraton, Little Rock, Arkansas. This conference will offer DEA registered Manufacturers, Distributors, Pharmacists, Importers or Exporters the...
Read More

Free CE Available for Pharmacists and Techs on Prescription Monitoring Program Data Integrity

Posted 3/15/2024

Take advantage of this free ACPE accredited educational opportunity providing 1 hour of continuing education for pharmacists and pharmacy technicians. This program, developed in partnership with the National Association of State Controlled Substances Authorities (NASCSA) a 501(C)(3) nonprofit...
Read More

Surescripts Issues Advisory to pharmacies, pharmacy computer vendors, and electronic health records companies connected to their e-prescribing network

Posted 2/18/2024

February 14, 2024 - Surescripts last week issued the following Advisory to pharmacies, pharmacy computer vendors and electronic health records companies connected to their e-prescribing network.

Description: As of August 28, 2023, the electronic transfer...
Read More

DEA Extends Comment Period on Disposal

Posted 2/16/2024

The Regulatory Drafting and Policy Support Section of the US Drug Enforcement Administration is looking for additional comments on the disposal APRN published on 10-31-2023 at Read More

Administration Announces Update on Overdose Prevent Strategy

Posted 2/4/2024

On Feb. 1, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule that updates regulations for Opioid Treatment Programs (OTP) and the standards for treatment of opioid use disorder (OUD). The rule makes some COVID-19-related flexibilities permanent, including...
Read More

All news & announcements

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors

State Controlled Substance and PMP Database

Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us. For the District of Columbia, Guam, and Puerto Rico, please use the button on the left for the inclusive drop down list.

Please use this form to contact Ana Lazarides

* Please do not submit patient health information (PHI).